REFERENCES
1. Mazzei FG, Gentili F, Guerrini S, et al. MR lymphangiography: a practical guide to perform it and a brief review of the literature from a technical point of view. Biomed Res Int 2017;2017:2598358.
2. Mitsumori LM, McDonald ES, Wilson GJ, Neligan PC, Minoshima S, Maki JH. MR lymphangiography: how I do it. J Magn Reson Imaging 2015;42:1465-77.
3. Mazzei MA, Gentili F, Mazzei FG, et al. High-resolution MR lymphangiography for planning lymphaticovenous anastomosis treatment: a single-centre experience. Radiol Med 2017;122:918-27.
4. Liu NF, Yan ZX, Wu XF, Luo Y. Magnetic resonance lymphography demonstrates spontaneous lymphatic disruption and regeneration in obstructive lymphedema. Lymphology 2013;46:56-63.
5. Chang DW, Suami H, Skoracki R. A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg 2013;132:1305-14.
6. Mitsumori LM, McDonald ES, Neligan PC, Maki JH. Peripheral magnetic resonance lymphangiography: techniques and applications. Tech Vasc Interv Radiol 2016;19:262-72.
7. White RD, Weir-McCall JR, Budak MJ, Waugh SA, Munnoch DA, Sudarshan TA. Contrast-enhanced magnetic resonance lymphography in the assessment of lower limb lymphoedema. Clin Radiol 2014;69:e435-44.
8. Cellina M, Oliva G, Menozzi A, Soresina M, Martinenghi C, Gibelli D. Non-contrast magnetic resonance lymphangiography: an emerging technique for the study of lymphedema. Clin Imaging 2019;53:126-33.
9. Cellina M, Gibelli D, Floridi C, Oliva G. Volumetric analysis of non-contrast magnetic resonance lymphangiography in patients affected by lower extremities primary lymphedema. Radiol Med 2020;125:432-5.
10. Nagase T, Gonda K, Inoue K, et al. Treatment of lymphedema with lymphaticovenular anastomoses. Int J Clin Oncol 2005;10:304-10.
11. Long X, Zhang J, Zhang D, et al. Microsurgery guided by sequential preoperative lymphography using 68Ga-NEB PET and MRI in patients with lower-limb lymphedema. Eur J Nucl Med Mol Imaging 2017;44:1501-10.
12. Linnitt N. Lymphoedema: recognition, assessment and management. Br J Community Nurs 2005;10:S20-6.
13. Liu NF, Lu Q, Liu PA, Wu XF, Wang BS. Comparison of radionuclide lymphoscintigraphy and dynamic magnetic resonance lymphangiography for investigating extremity lymphoedema. Br J Surg 2010;97:359-65.
14. Lu Q, Xu J, Liu N. Chronic lower extremity lymphedema: a comparative study of high-resolution interstitial MR lymphangiography and heavily T2-weighted MRI. Eur J Radiol 2010;73:365-73.
15. Liu NF, Lu Q, Jiang ZH, Wang CG, Zhou JG. Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography. J Vasc Surg 2009;49:980-7.
16. Lohrmann C, Földi E, Bartholomä JP, Langer M. MR imaging of the lymphatic system: distribution and contrast enhancement of gadodiamide after intradermal injection. Lymphology 2006;39:156-63.
17. Lu Q, Bui D, Liu NF, Xu JR, Zhao XH, Zhang XF. Magnetic resonance lymphography at 3T: a promising noninvasive approach to characterise inguinal lymphatic vessel leakage. Eur J Vasc Endovasc Surg 2012;43:106-11.
18. Baz AA, Hassan TA, Atta A, El kholy MS. Role of contrast enhanced MRI lymphangiography in evaluation of lower extremity lymphatic vessels for patients with primary lymphedema. The Egyptian Journal of Radiology and Nuclear Medicine 2018;49:776-81.
19. Arrivé L, Derhy S, Dahan B, et al. Primary lower limb lymphoedema: classification with non-contrast MR lymphography. Eur Radiol 2018;28:291-300.
20. Arrivé L, Derhy S, Dlimi C, El Mouhadi S, Monnier-Cholley L, Becker C. Noncontrast magnetic resonance lymphography for evaluation of lymph node transfer for secondary upper limb lymphedema. Plast Reconstr Surg 2017;140:806e-11e.
21. Arrivé L, Derhy S, El Mouhadi S, Monnier-Cholley L, Menu Y, Becker C. Noncontrast magnetic resonance lymphography. J Reconstr Microsurg 2016;32:80-6.
22. Notohamiprodjo M, Baumeister RG, Jakobs TF, et al. MR-lymphangiography at 3.0 T--a feasibility study. Eur Radiol 2009;19:2771-8.
23. Lu Q, Delproposto Z, Hu A, et al. MR lymphography of lymphatic vessels in lower extremity with gynecologic oncology-related lymphedema. PLoS One 2012;7:e50319.
24. Bae JS, Yoo RE, Choi SH, et al. Evaluation of lymphedema in upper extremities by MR lymphangiography: Comparison with lymphoscintigraphy. Magn Reson Imaging 2018;49:63-70.
25. Liu N, Zhang Y. Magnetic Resonance lymphangiography for the study of lymphatic System in lymphedema. J Reconstr Microsurg 2016;32:66-71.
26. Lohrmann C, Foeldi E, Speck O, Langer M. High-resolution MR lymphangiography in patients with primary and secondary lymphedema. AJR Am J Roentgenol 2006;187:556-61.
27. Liu NF, Yan ZX, Wu XF. Classification of lymphatic-system malformations in primary lymphoedema based on MR lymphangiography. Eur J Vasc Endovasc Surg 2012;44:345-9.
28. Zeltzer AA, Brussaard C, Koning M, et al. MR lymphography in patients with upper limb lymphedema: The GPS for feasibility and surgical planning for lympho-venous bypass. J Surg Oncol 2018;118:407-15.
29. Liu NF, Wang BS. Functional lymphatic collectors in breast cancer-related lymphedema arm. Lymphat Res Biol 2014;12:232-7.
30. Maki JH, Neligan PC, Briller N, Mitsumori LM, Wilson GJ. Dark blood magnetic resonance lymphangiography using dual-agent relaxivity contrast (DARC-MRL): a novel method combining gadolinium and iron contrast agents. Curr Probl Diagn Radiol 2016;45:174-9.
31. Liu N, Wang C, Sun M. Noncontrast three-dimensional magnetic resonance imaging vs lymphoscintigraphy in the evaluation of lymph circulation disorders: a comparative study. J Vasc Surg 2005;41:69-75.
32. Borri M, Gordon KD, Hughes JC, et al. Magnetic resonance imaging-based assessment of breast cancer-related lymphoedema tissue composition. Invest Radiol 2017;52:554-61.
33. Shinaoka A, Koshimune S, Yamada K, et al. Correlations between tracer injection sites and lymphatic pathways in the leg: a near-infrared fluorescence lymphography study. Plast Reconstr Surg 2019;144:634-42.
34. Clough RE. Magnetic resonance imaging to guide surgical practice. Eur J Vasc Endovasc Surg 2012;43:112-3.
35. Torres Lacomba M, Yuste Sánchez MJ, Zapico Goñi A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ 2010;340:b5396.
36. Mihara M, Hara H, Araki J, et al. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PLoS One 2012;7:e38182.
37. Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg 2006;243:313-5.
38. Lin CH, Ali R, Chen SC, et al. Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema. Plast Reconstr Surg 2009;123:1265-75.
39. Brorson H. Liposuction gives complete reduction of chronic large arm lymphedema after breast cancer. Acta Oncol 2000;39:407-20.
40. Brorson H, Svensson H. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plast Reconstr Surg 1998;102:1058-67; discussion 1068.
41. Ridner SH, Dietrich MS, Cowher MS, et al. A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis. Ann Surg Oncol 2019;26:3250-9.
42. Semelka RC, Ramalho M, Jay M. Summary of special issue on gadolinium bioeffects and toxicity with a look to the future. Magn Reson Imaging 2016;34:1399-401.
43. Guideline on the use of gadolinium-containing MRI contrast agents in patient with renal impairment, Version 3. 2019, The Royal Australian and New Zealand College of Radiologists. Available from: https://www.ranzcr.com/documents/553-revised-college-guidelines-for-gadolinium-containing-mri-contrast-agents/file. [Last accessed on 5 Aug 2021].
44. Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol 2017;16:564-70.
45. Murata N, Murata K, Gonzalez-Cuyar LF, Maravilla KR. Gadolinium tissue deposition in brain and bone. Magn Reson Imaging 2016;34:1359-65.
46. FDA Drug Safety Communication: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-gadolinium-based-contrast-agents-gbcas-are-retained-body. [Last accessed on 5 Aug 2021].
